Article Data

  • Views 318
  • Dowloads 38

Original Research

Open Access

Conditioned Pain Modulation Evoked by Different Intensities of Mechanical Stimuli Applied to the Craniofacial Region in Healthy Men and Women

  • Yuka Oono1
  • Kelun Wang1,2
  • Peter Svensson3,4
  • Lars Arendt-Nielsen1,*,

1Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, DK-9220 Aalborg E, Denmark

2Aalborg Hosp, Dept Oral & Maxillofacial Surg, Aalborg, Denmark

3Aarhus Univ, Sch Dent, Dept Clin Oral Physiol, Aarhus, Denmark

4Aarhus Univ Hosp, MindLab, Ctr Functionally Integrat Neurosci, DK-8000 Aarhus, Denmark

DOI: 10.11607/jofph.25.4.10 Vol.25,Issue 4,December 2011 pp.364-375

Published: 30 December 2011

*Corresponding Author(s): Lars Arendt-Nielsen E-mail: LAN@HST.AAU.DK

Abstract

Aims: To investigate systematically whether conditioned pain modulation (CPM) evoked by tonic mechanical stimuli applied to the craniofacial region is intensity-, assessment site–, and gender-dependent. Methods: Twenty healthy men and 20 women participated in four sessions. Tonic painful mechanical stimulation was applied to pericranial muscles by a mechanical headband pressure device. The pressures applied to four probes were adjusted via pain feedback from a 0 to 10 electronic visual analog scale (VAS) to generate different pain levels (VAS0, VAS1, VAS3, or VAS5) for 10 minutes. Pressure pain thresholds (PPTs) and pressure pain tolerance thresholds (PPTols) were assessed from right masseter muscle and left forearm by pressure algometry before, during, immediately after, 10 minutes after, and 20 minutes after the conditioning stimulus (CS). Data were analyzed with multilevel ANOVAs. Results: PPT values normalized to baseline recordings were not dependent on gender or assessment site, but dependent on intensity (P < .001) and time (P < .001). The most painful CS (VAS5) was associated with the highest PPT increases (32.6% ± 3.3%, mean value for the two assessment sites and two genders) during CS compared to all other intensities of CS (P < .001). PPTol values normalized to baseline recordings were also not dependent on gender or assessment site, but dependent on intensity (P < .001) and time (P < .001). The most painful CS (VAS5) was associated with higher PPTol increases (11.2% ± 2.8%, mean value for the two assessment sites and two genders) during CS (P < .001). Conclusion: CPM evoked by mechanical stimulation of the craniofacial region is intensity-dependent but not assessment site– or gender-dependent.

Keywords

conditioned pain modulation (CPM);diffuse noxious inhibitory control (DNIC);experimental craniofacial pain;gender differences;trigeminal system

Cite and Share

Yuka Oono,Kelun Wang,Peter Svensson,Lars Arendt-Nielsen. Conditioned Pain Modulation Evoked by Different Intensities of Mechanical Stimuli Applied to the Craniofacial Region in Healthy Men and Women . Journal of Oral & Facial Pain and Headache. 2011. 25(4);364-375.

References

1. Dao TT, LeResche L. Gender differences in pain. J Orofac Pain 2000;14:169–84.

2. Bragdon EE, Light KC, Costello NL, et al. Group differences in pain modulation: Pain-free women compared to pain-free men and to women with TMD. Pain 2002;96:227–237.

3. Bezov D, Ashina S, Jensen R, Bendtsen L. Pain perception studies in tension-type headache. Headache 2011;51: 262–271.

4. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurons in the rat. Pain 1979;6:283–304.

5. Hu JW. Response properties of nociceptive and non-nociceptive neurons in the rat’s trigeminal subnucleus caudalis (medullary dorsal horn) related to cutaneous and deep craniofacial afferent stimulation and modulation by diffuse noxious inhibitory controls. Pain 1990;41:331–345.

6. Raboisson P, Dallel R, Clavelou P, Sessle BJ, Woda A. Effects of subcutaneous formalin on the activity of trigeminal brain stem nociceptive neurones in the rat. J Neurophysiol 1995;73:496–505.

7. Le Bars D. The whole body receptive field of dorsal horn multireceptive neurons. Brain Res Rev 2002;40:29–44.

8. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurons, supraspinal involvement and theoretical implications. Pain 1979;6:305–327.

9. Price DD, McHaffie JG. Effects of heterotopic conditioning stimuli on first and second pain: A psychological evaluation in humans. Pain 1988;34:245–252.

10. Willer JC, De Broucker T, Le Bars D. Encoding of nociceptive thermal stimuli by diffuse noxious inhibitory controls in humans. J Neurophysiol 1989;62:1028–1038.

11. De Broucker T, Cesaro P, Willer JC, Le Bars D. Diffuse noxious inhibitory controls in man. Brain 1990;113: 1223–1234.

12. Le Bars D, Villanueva L, Bouhassira D, Willer JC. Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol Fiziol Eksp Ter 1992;4:55–65.

13. Mason AG, Newton JP, Cadden SW. Modulation of an inhibitory jaw reflex by remote noxious stimulation: Effects of spatial conditioning factors. Eur J Oral Sci 2007;115: 371–377.

14. Yarnitsky D, Arendt-Nielsen L, Bouhassira D, et al. Recommendations on terminology and practice of psychophysical DNIC testing [commentary]. Eur J Pain 2010;14:339.

15. Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain 1991; 46:125–132.

16. Tommaso MD, Difruscolo O, Sardaro M, et al. Effects of remote cutaneous pain on trigeminal laser-evoked potentials in migraine patients. J Headache Pain 2007;8:167–174.

17. Maixner W, Fillingim R, Booker D, Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 1995;63:341–351.

18. King CD, Wong F, Currie T, Mauderli AP, Fillingim RB, Riley JL III. Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain 2009;143:172–178.

19. Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain 2005;118:215–223.

20. Sandrini G, Rossi P, Milanov I, Serrao M, Cecchini AP, Nappi G. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia 2006;26:782–789.

21. Ge HY, Madeleine P, Arendt-Nielsen L. Sex differences in temporal characteristics of descending inhibitory control: An evaluation using repeated bilateral experimental induction of muscle pain. Pain 2004;110:72–78.

22. Staud R, Robinson ME, Vierck Jr CJ, Price DD. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003;101:167–174.

23. Arendt-Nielsen L, Sluka KA, Nie HL. Experimental muscle pain impairs descending inhibition. Pain 2008;140:465–471.

24. Pud D, Sprecher E, Yarnitsky D. Homotopic and heterotopic effects of endogenous analgesia in healthy volunteers. Neurosci Lett 2005;380:209–213.

25. Quiton RL, Greenspan JD. Sex differences in endogenous pain modulation by distracting and painful conditioning stimulation. Pain 2007;132(suppl 1):S134–S149.

26. Popescu A, LeResche L, Truelove EL, Drangsholt MT. Gender differences in pain modulation by diffuse noxious inhibitory controls: A systematic review. Pain 2010;50:309–318.

27. Wang K, Svensson P, Sessle BJ, Cairns BE, Arendt-Nielsen L. Painful conditioning stimuli of the craniofacial region evokes widespread DNIC responses in men and women. J Orofac Pain 2010;24:255–261.

28. Sowman PF, Wang K, Svensson P, Arendt-Nielsen L. Diffuse noxious inhibitory control evoked by tonic craniofacial pain in humans. Eur J Pain 2011;15:139–145.

29. Svensson P, Hashikawa CH, Casey KL. Site- and modality-specific modulation of experimental muscle pain in humans. Brain Res 1999;851:32–38.

30. Bouhassira D, Le Bars D, Villanueva L. Heterotopic activation of A delta and C fibers triggers inhibition of trigeminal and spinal convergent neurons in the rat. J Physiol 1987;389: 301–317.

31. Melzack R. The McGill pain questionnaire: Major properties and scoring methods. Pain 1975;1:277–299.

32. Drewes AM, Helweg-Larsen S, Petersen P, et al. McGill pain questionnaire translated into Danish: Experimental and clinical findings. Clin J Pain 1993;9:80–87.

33. Bigal ME, Lipton RB. Tension-type headache: Classification and diagnosis. Curr Pain Headache Rep 2005;9:423–429.

34. Pud D, Granovsky Y, Yarnitsky D. The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans. Pain 2009;144:16–19.

35. Sessle BJ, Hu JW, Dubner R, Lucier GE. Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). II. Modulation of responses to noxious and nonnoxious stimuli by periaqueductal gray, nucleus raphe magnus, cerebral cortex, and afferent influences, and effect of naloxone. J Neurophysiol 1981;45:193–207.

36. Arendt-Nielsen L, Gotliebsen K. Segmental inhibition of laser-evoked brain potentials by ipsi- and contralaterally applied cold pressor pain. Eur J Appl Physiol Occup Physiol 1992;64:56–61.

37. Kakigi R. Diffuse noxious inhibitory control. Reappraisal by pain-related somatosensory evoked potentials following CO2 laser stimulation. J Neurol Sci 1994;125:198–205.

38. Ellrich J, Treede R. Characterization of blink reflex interneurons by activation of diffuse noxious inhibitory controls in man. Brain Res 1998;803:161–168.

39. Oono Y, Fujii K, Motohashi K, Umino M. Diffuse noxious inhibitory controls triggered by heterotopic CO2 laser conditioning stimulation decreased the SEP amplitudes induced by electrical tooth stimulation with different intensity at an equally inhibitory rate. Pain 2008;136:356–365.

40. Motohashi K, Umino M. Heterotopic painful stimulation decreases the late component of somatosensory evoked potentials induced by electrical tooth stimulation. Cogn Brain Res 2001;11:39–46.

41. Romaniello A, Arendt-Nielsen L, Cruccu G, Svensson P. Modulation of trigeminal laser evoked potentials and laser silent periods by homotopical experimental pain. Pain 2002; 98:217–228.

42. Valeriani M, Le Pera D, Restuccia D, et al. Segmental inhibition of cutaneous heat sensation and of laser-evoked potentials by experimental muscle pain. Neuroscience 2005;136:301–309.

43. Valeriani M, Tinazzi M, Le Pera D, et al. Inhibitory effect of capsaicin evoked trigeminal pain on warmth sensation and warmth evoked potentials. Exp Brain Res 2005;160:29–37.

44. Villanueva L, Le Bars D. The activation of bulbo-spinal controls by peripheral nociceptive inputs: Diffuse noxious inhibitory controls. Biol Res 1995;28:113–125.

45. Tousignant-Laflamme Y, Page S, Goffaux P, Marchand S. An experimental model to measure excitatory and inhibitory pain mechanisms in humans. Brain Res 2008;1230:73–79.

46. Granot M, Weissman-Fogel I, Crispel Y, et al. Determinants of endogenous analgesia magnitude in a diffuse noxious inhibitory control (DNIC) paradigm: Do conditioning stimulus painfulness, gender and personality variables matter?Pain 2008;136:142–149.

47. Pud D, Golan Y, Pesta R. Hand dominancy—A feature affecting sensitivity to pain. Neurosci Lett 2009;467:237–240.

48. Sarlani E, Farooq N, Greenspan JD. Gender and laterality differences in thermosensation throughout the perceptible range. Pain 2003;106:9–18.

49. Serrao M, Rossi P, Sandrini G, et al. Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans. Pain 2004;112:353–360.

50. Graven-Nielsen T, Babenko V, Svensson P, Arendt-Nielsen L. Experimentally induced muscle pain induces hypoalgesia in heterotopic deep tissues, but not in homotopic deep tissues. Brain Res 1998;787:203–210.

51. Svensson P, McMillan AS, Graven-Nielsen T, Wang K, Arendt-Nielsen L. Modulation of an inhibitory reflex in single motor units in human masseter by tonic painful stimulation. Pain 1999;83:441–446.

52. Pomeranz B, Wall PD, Weber WV. Cord cells responding to fine myelinated afferents from viscera, muscle and skin. J Physiol 1968;199:511–532.

53. Sessle BJ, Hu JW, Amano N, Zhong G. Convergence of cutaneous, tooth pulp, visceral, neck and muscle afferents onto nociceptive and non-nociceptive neurones in trigeminal subnucleus caudalis (medullary dorsal horn) and its implications for referred pain. Pain 1986;27:219–235.

54. Mørch CD, Hu JW, Arendt-Nielsen L, Sessle BJ. Convergence of cutaneous, musculoskeletal, dural and visceral afferents onto nociceptive neurons in the first cervical dorsal horn. Eur J Neurosci 2007;26:142–154.

55. France CR, Suchowiecki S. A comparison of diffuse noxious inhibitory controls in men and women. Pain 1999;81:77–84.

56. Baad-Hansen L, Poulsen HF, Jensen HM, Svensson P. Lack of sex differences in modulation of experimental intraoral pain by diffuse noxious inhibitory controls (DNIC). Pain 2005; 116:359–365.

57. Ge HY, Madeleine P, Arendt-Nielsen L. Gender differences in pain modulation evoked by repeated injections of glutamate into the human trapezius muscle. Pain 2005;113: 134–140.

58. Tousignant-Laflamme Y, Marchand S. Excitatory and inhibitory pain mechanisms during the menstrual cycle in healthy women. Pain 2009;146:47–55.

Abstracted / indexed in

Science Citation Index (SCI)

Science Citation Index Expanded (SCIE)

BIOSIS Previews

Scopus

Cumulative Index to Nursing and Allied Health Literature (CINAHL)

Submission Turnaround Time

Conferences

Top